Filing Flows › Longevity Health Holdings (XAGE) › Q1 2026 › vs Q4 2025
Longevity Health Holdings (XAGE) Q1 2026 vs Q4 2025 (quarter over quarter)
Longevity Health Holdings's revenue fell $81K (-17%) from $473K in Q4 2025 to $392K in Q1 2026.
Longevity Health Holdings, Q1 2026: revenue $392K (-23% year over year), operating margin -339.1%, net loss $1.4M, operating cash flow −$485K. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $392K | $473K | −$81K | -17% |
| Net loss | $1.4M | $2.1M | −$652K | -31% |
| Costs & expenses | $1.8M | $2.8M | −$957K | -34% |
| Operating costs | $1.7M | $2.7M | −$1.0M | -37% |
| Interest & other, net | $103K | −$224K | $327K | — |
| Cost of revenue | $155K | $205K | −$50K | -25% |
| Research & development | $55K | $104K | −$49K | -47% |
| Sales & marketing | $271K | $336K | −$65K | -19% |
| Other operating costs | $1.2M | $2.1M | −$860K | -41% |
| Operating cash sources | $1.4M | $2.1M | −$652K | -31% |
| Depreciation & amortization | $15K | $16K | −$1K | -8% |
| Share-based compensation | $146K | $194K | −$48K | -25% |
| Working capital & other | $785K | $1.6M | −$781K | -50% |
| Cash used in operations | $485K | $306K | $179K | +58% |
| Net loss absorbed | $1.4M | $2.1M | −$652K | -31% |
Questions
How much did Longevity Health Holdings's revenue grow quarter over quarter in Q1 2026?
Longevity Health Holdings's revenue fell $81K (-17%) from $473K in Q4 2025 to $392K in Q1 2026.